Maximus TRT Reviews: What We Checked Before You Pay

Maximus TRT reviews support a closer look for cash-pay adults, not a blanket recommendation. Cream and injections advertise $99.99 a month with a six-month commitment; labs cost extra. Confirm the medicine, full quote and cancellation terms before paying. Need insurance-billed care, a confirmed FDA-approved product or near-term fertility care? Start with that requirement instead.

Worth a closer look if: you're paying cash, you've had your testosterone properly checked, and you want to compare Maximus's treatment formats with your clinician.

Start somewhere else if: you need insurance-billed care, an FDA-approved product Maximus has not confirmed, or fertility-focused care. Want the freedom to leave after month two? Do not mistake the lowest advertised rate for a month-to-month plan.^{1 2 3}

By TRT Provider Guide · Last verified September 2026 (sources checked September 11, 2026)
Editorial research. Not clinically reviewed. This is educational information, not medical advice.

Disclosure: TRT Provider Guide may earn a commission from some providers linked on this site. This article uses direct source links, not affiliate enrollment links. See our affiliate disclosure.

What does Maximus charge by program and plan length?

Maximus's lowest ongoing rates require a longer commitment. The cream and injections reach $99.99 a month on a six-month plan; enclomiphene reaches that price on a twelve-month plan and is not testosterone replacement.¹

Provider-stated prices displayed on Maximus's own product pages, checked September 11, 2026. Each page notes that pricing can vary by prescribed amount, plan, and state.

The $99.99 number is real. It's also attached to a commitment, and the thing you're actually buying isn't the same across all four of their programs. Month to month, the programs above run $199.99 to $249.99. Labs cost extra.¹

Look at the last column. The cream and the injections get you to $99.99 with a six-month commitment. Enclomiphene gets you to the exact same $99.99 — but only on a twelve-month commitment. Same headline number. Double the lock-in.

It's sitting in plain sight on Maximus's own product pages. The price table compares monthly equivalents, not the amount due today. Ask for the total committed amount, billing dates and any first-month discount separately.^{1 4}

---

Who are we, and why aren't we deciding this for you?

We check the offer, the evidence and the terms so you can ask better questions before paying. We do not decide whether testosterone treatment is right for you.

TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.

The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.

---

What did we actually verify?

We checked public offers, policies, review records and primary medical sources on September 11, 2026. Reading a published claim verifies what the source says, not whether every patient's care matches it.

Verified September 11, 2026.

What we read: the four product pages in the price table · the testosterone hub and its program comparison table · the Terms of Use · the Return, Refund & Subscription Policy · the Billing & Subscriptions help article · the lab overview, costs and product pages · both BBB profiles found under Maximus's names and the public Maximus Tribe complaint record · the Trustpilot company profile · the published Araujo study abstract and Mulligan research paper · FDA materials, including its June 2026 warning letter · and clinical guidance. Sources are linked at the claims they support.

What we actually verified: the displayed plan prices and commitment lengths · the wording of the policies, including conflicts between them · the public compounding disclosures · the two BBB profiles and their different ratings · that Maximus states it does not accept insurance · and the findings reported in the two prevalence studies. These checks do not establish a patient-specific total, medication, license or outcome.

Provider-stated, not independently confirmed: Maximus's clinician and pharmacy credential claims, membership count, medical-advisor affiliations, service estimates, and outcome figures from its own studies. These are not independent proof of quality or typical results.

Could not confirm: a complete treatment-specific state list · the final consultation and membership charges for an individual plan · the full cost of required testing · the exact ingredients in an individual prescription · the specific clinician and dispensing pharmacy assigned to any one patient · a guaranteed clinical response time or medical-record transfer deadline. We've turned each of those into a question you can ask. They're at the bottom of this page.

What we did not do: we did not take any Maximus program, complete a checkout, time their support, or speak to their clinicians. This is a document check, not a personal treatment story.

---

Is Maximus TRT legit?

Maximus is an operating telehealth platform with published prescription-care and testing processes, but that is not a blanket quality or safety endorsement. Its terms say affiliated medical practices provide the care; individual clinician and pharmacy credentials still need checking, and FDA issued the company a warning letter about separate weight-loss marketing in June 2026.^{5 6 7}

Let's deal with the thing that scares people first.

Testosterone is a Schedule III controlled substance in the United States. It has accepted medical use and a recognized potential for misuse, and requires a valid prescription from an appropriately licensed prescriber.⁸

Maximus says labs are required before treatment and describes clinical review before a prescription. Those are provider-stated process requirements, not proof that every evaluation, prescription or shipment was handled correctly.⁶

The product pages display board-certified-doctor, pharmacy and certification claims. We did not independently verify every badge, an individual assigned clinician's license or the dispensing pharmacy. Ask for the names, not just the logos.¹

The BBB number worth checking at the source

An Innerbody review dated January 29, 2026 reports an “F” BBB rating. That is not the rating displayed on the Maximus Tribe profile we checked on September 11, 2026.^{9 10}

We opened the BBB profile directly on September 11, 2026.

The two BBB profiles list the same address and business-start date but have different complaint totals and grades. We have not added their complaint counts together because we cannot establish whether they overlap. The detailed complaint analysis below refers only to the Maximus Tribe profile.^{10 11}

Maximus Tribe's current BBB rating is B−. Not accredited. The BBB lists two reasons for the grade: 18 complaints filed against the business, and the length of time the business has taken to respond to complaints.¹⁰

That's a real grade with a real deduction behind it. It is not an F. A BBB grade is about the business record, not a medical license or a finding that the medicine is safe.

What the 18 complaints actually say

We read the public complaint entries. Here's the shape of the BBB's outcome summary:

“Answered” does not mean “resolved.” BBB explains that an answered complaint may be one where the customer did not accept the response or did not report satisfaction. The zero in its separate “unresolved” category does not mean every customer was satisfied.¹²

Eighteen complaints in three years is the published count for this profile. It is not a complaint rate: we do not know how many affected customers complained elsewhere or did not file a public complaint.

Which brings us to the part we found genuinely interesting.

The public response-date pattern

Read the complaint file in date order and something jumps out:

Our calculation: the calendar difference between the displayed complaint and business-response dates for these ten public entries. It is not a measurement of first contact, clinical support or refund completion.¹²

Seven complaints spanning four months were all answered on the same day — May 6, 2026. The three later complaints shown here received public replies in one to six days. But an older October 10, 2025 complaint shows a May 28, 2026 reply, so the record does not establish that the whole backlog was cleared on May 6.^{12 13}

So here's our honest read on Maximus support: this sample shows long delays in some public dispute responses and shorter delays in three later ones. It does not prove faster doctor messaging, that every issue was resolved, or that everyone will get an answer within a set time.

The FDA warning a trust check should include

On June 8, 2026, FDA sent a warning letter to Maximus Health, Inc., doing business as Maximus. It challenged marketing for compounded semaglutide and tirzepatide, including statements that could imply FDA evaluation or approval and a claim about FDA-approved pharmacies.⁷

This was not a TRT recall or an order banning Maximus's testosterone programs. It concerned other medicines sold by the same business. It belongs in a company trust review because it addresses claims transparency, but it does not establish that an individual testosterone prescription is defective.⁷

Our conclusion: do not use either a positive review score or a regulatory headline as a substitute for checking the exact medicine, clinician, pharmacy and contract.

---

Which Maximus programs are actually testosterone replacement?

Maximus's four standalone offers compared here are injectable testosterone, testosterone cream, oral testosterone, and enclomiphene. Enclomiphene contains no testosterone: it is a selective estrogen receptor modulator, or SERM, which can raise the hormone signals that stimulate the testicles rather than replace testosterone directly.^{1 14}

This matters more than any price on this page, because the medicine changes the cost, fertility questions, monitoring and clinical fit. Ending a subscription and changing treatment are separate decisions.

It also means a Maximus review may be reviewing a completely different medicine than the one you're considering. Check which program the person used.

The four programs, side by side

Treatment descriptions and prices are provider-stated. Fertility limitations are explained against primary research and specialty guidance below.^{1 15 3 14}

A few details worth knowing before choosing a treatment format:

Maximus says its injectable uses MCT oil. That's a formulation choice, not an approval status — more on that below. It does not prove a smoother or safer injection. Ask for the exact testosterone ingredient, concentration, carrier oil and pharmacy on your prescription.¹⁶

Maximus warns about cream transfer. Testosterone on treated skin can expose a partner or child through contact. Follow the instructions that come with your specific product, not something you read about a different cream. Ask the prescriber and pharmacist how to prevent contact exposure in your household.^{17 18}

Oral testosterone has a pill-and-meal routine. Maximus describes multiple capsules with a meal; the exact instructions belong on the prescription. That's a real daily habit, not a convenience upgrade.¹⁹

Why the cause of low testosterone matters for enclomiphene

Enclomiphene can raise LH (luteinizing hormone) and FSH (follicle-stimulating hormone) — the two signals your pituitary gland sends to your testicles. In trials involving men with secondary hypogonadism, it increased testosterone and maintained sperm counts; those results do not establish a benefit for every cause of low testosterone.¹⁴

But that only works if your testicles can still respond.

In primary hypogonadism, the main problem is in the testicles rather than the signal reaching them. Clinicians use LH and FSH, along with the full evaluation, to help distinguish that from a pituitary or hypothalamic signaling problem. This page cannot diagnose either condition from your results.²⁰

Maximus's lab policy includes LH and FSH. Those tests can help a clinician investigate the cause; they do not make an enclomiphene prescription automatically appropriate.^{21 20}

If a testicular or pituitary problem is suspected, a urologist or endocrinologist is the right next stop. Primary hypogonadism does not automatically rule out testosterone replacement or every Maximus program; it changes which treatment needs to be considered.²⁰

Approval is a separate question. A compounded enclomiphene medicine is not FDA-approved. Do not confuse it with clomiphene, an approved medicine whose use for men is off-label, meaning outside its approved use. hCG is another non-testosterone medicine: an approved hCG product such as Pregnyl has a labeled use for selected cases of male hypogonadotropic hypogonadism. That does not make adding hCG to TRT an approved guarantee of fertility preservation.^{22 23 3 24}

---

What can Maximus TRT cost in the first year?

The advertised monthly rate is not your care budget. The scenarios below total roughly $1,600 to $3,400 for twelve months of plan charges plus four assumed tests, including the test around the twelve-month anniversary; they are not complete personal quotes. Required extra testing, consultation charges and the actual prescription can change the bill.^{1 6 21 5}

Maximus's own Terms make it explicit: the testosterone program does not include at-home or in-person blood tests, and those are required for treatment.⁵

So let's build the number properly.

The lab side

Maximus's lab-cost help article lists at-home tests at $99, while the at-home kit product page displays $99.99 each. Its published lab process describes a baseline test before treatment plus follow-up testing at roughly one month, three months, and twelve months, subject to what your clinician requires.^{21 25 6}

Four tests at $99 each total $396. At the displayed $99.99 kit price, four total $399.96. That fourth test sits at the twelve-month boundary; a cash budget that ends before it is charged would include only the charges that actually fall inside that period.

One honest caveat, and it's Maximus's own inconsistency, not ours: the lab-cost article describes the $99 kit as covering a required panel, then elsewhere describes narrower home testing and directs fuller panels to Quest Diagnostics. The kit product page advertises ten markers. So $396 to $399.96 is a four-test assumption, not a guaranteed laboratory total. Get the exact required panel and its price in writing.^{21 25}

The baseline test in this model is only one collection. The public pages do not establish whether a second diagnostic morning test is included or what it would cost. Do not count a test performed after treatment starts as confirmation of the untreated baseline.^{20 6}

Twelve months, five budget scenarios

Modeled at the advertised ongoing rate × 12 months, assuming unchanged renewal prices, plus four tests priced at $99 to $99.99 each. Excludes first-month promotions, any extra required tests or consultation fees, taxes and financing charges. Unknown charges are not assumed to be zero.

Our calculations use the four product pages and the two published lab prices. The six-month-rate scenarios assume a second six-month term at the same rate; they are not a promise about renewal pricing.^{1 25 21 5}

That's a $1,800 swing on the same platform, based on the treatment and commitment selected in these scenarios.

Read that again, because it's the whole game. A headline price does not show the difference between these treatment-and-term combinations. It is not a reason to choose a medicine that does not fit your medical needs.

Three things that move your number

Your dose. Every product page says pricing varies by prescribed amount. The table above is the advertised rate, not a quote.¹

Promotions. Maximus displays first-month discounts on selected plans. Just don't build a twelve-month budget on a one-month price. Confirm the discount and the ongoing rate for the exact plan you choose.¹

Add-ons. Maximus sells a prescription multivitamin and separate annual lab plans. Its comprehensive lab page lists annual plans at $199.99 and $349.99 that renew automatically; it describes add-on panels separately as one-time purchases. An annual lab plan alongside treatment can mean two auto-renewing subscriptions, with renewal dates that may differ. Know both.²⁶

What the public prices still do not settle

There is a consultation-fee conflict worth resolving before paying. The testosterone hub says consultations and ongoing monitoring are included. The subscription section of the Terms lists video consultations, where applicable, alongside blood testing as excluded. The general billing article also lists consultation and membership fees among possible charges.^{15 5 2}

A complete first-year quote is not publicly established. The tables give you an auditable budget, not a made-up all-in price. For a cash-flow budget, add the charges due during your chosen twelve-month period, then list any anniversary test or renewal outside it separately. Our TRT cost guide provides a broader comparison framework.

Your exact number depends on the prescription, plan term and required care. Work out which program and commitment actually fit your situation before you're staring at a checkout screen.

→ Map your care route with Find My TRT Path

---

Is Maximus testosterone FDA-approved or compounded?

Maximus's product pages advertise compounding-pharmacy fulfillment, and the oral page explicitly calls its formulation custom-compounded. We did not identify a named FDA-approved finished testosterone product in the four offers reviewed. Compounded medicines are not FDA-approved; confirm the actual medicine and pharmacy rather than treating a general badge as a product label.^{1 19 22}

The reviewed product pages carry a “Licensed US compounding pharmacies” badge, and the oral page calls its formulation “custom-compounded.” They also carry a compounding disclaimer:¹

"Compounded medications are not approved or evaluated for safety, efficacy, or quality by the FDA."

Credit where it's earned: Maximus's injectable and cream pages carry explicit fertility warnings and side-effect information. That disclosure helps, but it does not prove that a particular formulation is safe for you or that the list covers every risk.^{16 17}

Ask how the clinician will monitor blood pressure, blood counts, symptoms and relevant prostate risks. FDA's 2025 labeling action added blood-pressure warnings. In June 2026, FDA requested removal of the prior age-related-hypogonadism limitation and revisions to prostate safety information. Neither action approved a compounded Maximus formulation. The Endocrine Society's July 2026 statement still calls for proper diagnosis, risk assessment and monitoring.^{27 28 29}

What compounded changes for you, in four specifics

1. Cash-pay is not the same as a coverage decision. Maximus states it does not accept insurance. That does not establish what a separate health plan would reimburse for a particular visit, laboratory test or medicine.²

2. A compounded preparation has no FDA-approved finished-product label. With an approved product, you get a label reviewed by the agency. With a compounded preparation, ask the pharmacy and prescriber for the exact ingredients, strength, instructions, storage limits and risk information.²²

3. Quality needs its own check. FDA does not review a compounded medicine for safety, effectiveness or quality before marketing. Poor compounding can lead to contamination or the wrong strength. A licensed pharmacy claim is not FDA product approval.²²

4. Refill and transfer options depend on the exact prescription. Ask which pharmacy dispenses it, whether that preparation can be supplied elsewhere, and what records a new clinician would need. If you ever need to transfer care, that matters.

None of this establishes that a particular compound is defective. It makes the approval status and pharmacy documentation matter, and you should know which medicine you're being offered before the card gets charged, not after.

The honest downside — and why it might not matter to you

Do not assume Maximus will dispense an FDA-approved testosterone product. We did not identify one by name in the reviewed offers. If having an FDA-approved label you can read, a product your insurance might cover, and a prescription a retail pharmacy can fill is your priority, make the exact product and dispensing arrangement a condition before paying.¹

But here's the flip side: a different formulation may address a specific need when an approved medicine does not. That is a reason to discuss the formulation with a clinician, not proof that a compound is better. FDA-approved oral testosterone products already exist, and approved products can also have clinician-directed dose adjustments. Compounding is not what makes oral treatment or individualized care possible.^{22 27}

Maximus's advertised MCT-oil injection, topical cream and oral offer give you formats to compare. The deciding question is whether the exact preparation meets a real medical need—not whether the marketing calls it customized.¹

So pick your lane honestly.

If an FDA-approved product is what you need, don't settle. Compare the providers that dispense one and check what they cover in your state.

→ Compare online TRT providers and what each one dispenses

---

Does Maximus TRT preserve fertility?

Maximus's program comparison table lists testosterone cream as maintaining fertility markers — with a footnote saying that applies when taken with enclomiphene. The cream's own product page states plainly that as a form of TRT it can suppress natural testosterone production and reduce sperm count. Neither the footnote nor a hormone result guarantees preserved fertility.^{15 17 3}

This is the finding we'd most want a friend to know before he paid.

On Maximus's main testosterone page, there's a four-column comparison table. The fertility row reads like this:

These are Maximus's advertising statements, not our findings of preserved fertility.¹⁵

Now open the cream's own product page. Same site. Same day. In plain body text:

"Fertility warning: As a form of TRT, the cream can suppress natural testosterone production and may reduce sperm count and fertility."

And in that page's FAQ: "Will testosterone cream affect fertility?" — "Yes."¹⁷

Here's the gap that can change your decision. The cream's $99.99 starting rate does not establish that enclomiphene is included. The hub gives a general $149.99–$199.99 range for combination protocols, not a patient-specific quote for the combination in that footnote. Confirm both the ingredients and the full combination price.^{17 15}

A man who scans that table and concludes the $99.99 cream guarantees fertility has taken away more than either the price or the footnote supports.

To be fair to Maximus: the footnote is right there on the table, and the product page carries a clear fertility warning. The limitation is disclosed, but the headline comparison can still be easy to misread.^{15 17}

That is why fertility belongs in the clinical discussion before you commit to a plan.

"Fertility markers" are not sperm

This distinction is worth slowing down for.

The public Maximus combination research we reviewed reports fertility-related hormone markers, including LH and FSH. Those hormone results are not the same as direct measurements of sperm or pregnancy outcomes.^{30 31}

LH and FSH are hormone signals. They are not sperm.

It is not the same evidence as a measured sperm count, motility, and shape. Those come from a semen analysis, which is a completely different test. A semen result also cannot guarantee a future pregnancy.³²

There is primary research on enclomiphene alone that measured sperm counts, rather than only hormone markers. It studied selected men with secondary hypogonadism and compared enclomiphene with testosterone gel. It does not prove that every Maximus testosterone-and-enclomiphene combination preserves fertility.¹⁴

Exogenous testosterone — testosterone you take, in any form — can suppress spermatogenesis, the process of making sperm. That's well established. The degree of suppression and any later recovery vary; neither infertility nor preserved fertility is guaranteed.³

So here's the question to ask before treatment:

If children are on the table — this year or in five years — ask a fertility-aware clinician whether a baseline semen analysis, fertility evaluation or sperm-banking discussion belongs in your plan. A hormone panel cannot replace that conversation. Cost and access vary; this is not a test every reader must order independently.^{32 3}

Our TRT and fertility guide explains the questions to take to that visit.

If fertility is part of this decision, a general online TRT program probably isn't your first stop. A urologist, reproductive urologist, or fertility-aware clinician is.

→ Map your fertility-first care route with Find My TRT Path

---

What blood work does Maximus require, including repeat testing?

Maximus says it requires baseline labs and accepts qualifying outside bloodwork from the past six months. Its public pages do not establish a universal two-morning-test requirement or whether the second diagnostic test is included. The Endocrine Society's July 2026 statement calls for at least two early-morning, fasting testosterone tests, alongside symptoms and an accurate clinical assessment.^{21 6 29}

Quick definitions, because these words get thrown around:

• Total testosterone — all the testosterone in your blood, bound and unbound.
• Free testosterone — the small fraction that's unbound and available to your tissues.
• SHBG (sex hormone-binding globulin) — a protein that binds testosterone. Along with other factors, it affects how much is free.
• LH and FSH — the pituitary signals that tell your testicles what to do. Clinicians use them to help distinguish a signal problem from a testicle problem.
• Hematocrit — the percentage of your blood made of red blood cells. Testosterone can push it up, which is why it gets monitored.
• PSA (prostate-specific antigen) — a prostate-related marker considered with age, history and other risk factors; it is not a cancer diagnosis by itself.²⁰

Maximus's at-home product page advertises all of those markers among a ten-marker panel. Its lab policy lists total testosterone, free testosterone or SHBG, LH and FSH for enclomiphene, with PSA and hematocrit additionally required for testosterone protocols. The conflicting home-panel descriptions mean you should confirm the actual order, not assume one kit covers every requirement.^{25 21}

Maximus describes an at-home Tasso collection device that attaches to the shoulder area and uses a small lancet rather than a finger-prick collection. That is the stated collection method, not our tested finding about comfort or accuracy.²⁵

Can you bring your own labs or use Quest?

Maximus says uploading qualifying outside labs is free; paying your outside clinician or lab is a separate matter. Its help article lists Quest prices from $19.99 to $115 depending on the panel. That range is not a promise that the lowest-priced test covers every required marker.²¹

The same policy says accounts set to home testing are automatically charged for kits at required intervals. Ask about each charge, and arrange any switch to outside testing with support rather than assuming an upload stops automatic orders.²¹

What the guidelines actually say

The clinical question has three parts: symptoms or signs, consistently low testosterone, and a clinician's assessment of the cause. A cutoff near 300 ng/dL is a commonly used reference—not a universal diagnosis and not a target to chase.²⁹

The Endocrine Society's guideline calls for confirmation with repeat morning fasting measurements using accurate tests. Its July 16, 2026 statement makes the two-test requirement explicit. FDA's clinical presentation also describes symptoms or signs plus low morning results on at least two occasions when summarizing the diagnostic framework.^{20 29 23}

Testosterone results can change with timing, illness and the test method. That is why one result, a symptom quiz or an “optimal” range on a sales page cannot make the diagnosis.²⁹

What to ask Maximus: “Will my clinician require two separate early-morning testosterone results before diagnosing deficiency? Who orders the second test, what collection instructions apply, and what will it cost?” Accepting an older lab panel is not the same as establishing that your diagnostic evaluation is complete.

About that "1 in 4 men" headline

Maximus's main testosterone page uses a “1 in 4” claim and cites Araujo and colleagues' 2007 research. Its marketing also references Mulligan and colleagues' 2006 study. The populations and definitions matter more than the headline.^{15 1}

We checked the Araujo study abstract and the full Mulligan paper.

These are different study populations and definitions, not directly comparable rates of who needs treatment today.^{33 34}

Araujo's roughly 24% low-total-testosterone finding does support “about one in four” as a laboratory statistic in that study population. It does not mean one in four men had symptomatic deficiency or needed TRT. The much lower 5.6% figure answers a different question.³³

Mulligan's study concerns men 45 and older attending primary care, not all men over 30. Its 38.7% figure cannot be substituted for Araujo's result. Neither study tested whether treating men with normal testosterone improves their symptoms.^{34 33}

But the takeaway for you is worth keeping:

A prevalence statistic is a fact about a population. It is not a fact about you. Your symptoms, repeated results and the clinician's assessment matter together.²⁹

Note too that Maximus's page discusses symptoms “even if you test at normal clinical ranges.” That marketing language is not a diagnosis. The Endocrine Society's current statement still requires compatible symptoms and consistently low, accurately measured results, with other causes considered. Ask the clinician to explain the diagnosis and evidence rather than accepting “optimization” as the reason for treatment.^{15 29}

If you've had one lab result and nobody walked you through it, ask your clinician about a repeat early-morning test before committing to treatment. Confirm the testing cost and any coverage instead of assuming it is included.

→ See how at-home and in-person TRT testing compare

---

What happens if you cancel Maximus or need to stop treatment?

Maximus says you can turn off auto-renewal at any time, but that normally does not end the current committed term or refund it. Its Terms also contain a health-related cancellation exception that the newer refund policy does not explain. Ask for written confirmation of what applies to your plan before assuming either that all remaining charges disappear or that no exception exists.^{5 4}

This is the part worth reading twice, because the public documents do not say exactly the same thing.

From the Terms of Use:

"Participants may request to cancel their participation in the Program mid-term; however, they will remain responsible for fulfilling the payment obligations for the remainder of the commitment term."⁵

From the same Terms, immediately after that restriction:

Section 4.1 says a participant unable to continue because of health-related issues, as determined by a healthcare provider, may cancel the commitment without further charges. Documentation may be required; already-shipped medication is not refundable.⁵

From the Return, Refund & Subscription Policy:

"For committed multi-month plans, no refunds are issued for the remainder of the committed term, whether the plan was paid in full up front or is being paid in installments."⁴

That July 15, 2026 policy also says committed plans are not eligible for early termination. It does not explain how that wording fits the health exception in the Terms. We cannot settle which provision governs an individual contract from those pages alone. Ask: “Does the health-related cancellation exception in section 4.1 apply to this plan, and who determines whether it applies?”

The refund policy says prescription sales are final once medication has been dispensed and shipped, and rendered consultation and laboratory services are non-refundable. It also offers a no-cost replacement for a damaged, defective, incorrect or unusable order reported within three days of delivery.⁴

Published instructions, not a cancellation flow we personally tested.^{4 5}

What that means in dollars

Assume an installment plan at $99.99 a month, two full monthly charges already paid, no promotion, no price change and no applicable exception:

• Leave a twelve-month enclomiphene plan after those two charges: 10 × $99.99 = $999.90 in remaining plan payments under the ordinary commitment rule.
• Leave a six-month injectable plan after those two charges: 4 × $99.99 = $399.96 in remaining plan payments under that rule.

These are examples of remaining contractual payments, not a forecast of your medical response or a statement that every cancellation owes the same amount.^{5 4}

There's also a difference between pausing and cancelling. Maximus says ordinary pauses take effect at the next billing cycle and later resume on the selected end date. Its pause article says Buy Now, Pay Later installments continue during a pause. Do not assume a pause removes a committed balance.³⁵

And then Maximus says this

Buried in its own subscription policy, Maximus writes:

"If you are new to a protocol and want to evaluate whether it is right for you, we recommend starting with a month-to-month plan. This gives you time to complete your blood work, assess your response, and consult with your provider before committing to a multi-month plan, which cannot be ended early."⁴

Maximus itself recommends a month-to-month plan for people who are new to a protocol and want to assess it before committing.

That's a useful thing for a subscription company to publish. It belongs next to the discounted price, not just in the policy. We agree with the financial logic when flexibility matters more to you than the lower monthly rate.

For the subscription decision, month to month buys flexibility. At the displayed cream or injection rates, two month-to-month plan payments total $399.98, compared with $199.98 for the first two months at the six-month rate—a $200 premium before labs and other charges. The lower rate still carries the longer commitment.

Whether treatment is working, whether side effects are acceptable and when to reassess are decisions for you and your clinician—not a two-month trial rule from this page. Before moving to a longer plan, confirm the price, new commitment and any change fees in writing.^{1 5}

That's the company's own plan-selection advice. It does not require you to choose a longer commitment later.

Before you pick a plan length, get clear on which program and care route actually fit your labs, your state, and your fertility plans — then take your questions to checkout.

→ Use Find My TRT Path to sort your options

---

What do Maximus customers actually report?

At this check, Maximus's Trustpilot profile displayed 4.4 out of 5 from 1,067 reviews and said it replies to all negative reviews, typically within 48 hours. Those are platform-reported public-review metrics, not a clinical response guarantee. The BBB record adds complaint details, but neither source measures medical safety or proves typical results.^{36 12}

Read each record for the question it can answer: what a customer reported, what the company replied, and whether a resolution was recorded.

Checked September 11, 2026. The separate Maximus Health Inc. BBB profile is shown in the legitimacy section, not merged into this table.^{36 12 11}

Both sources can contain service, billing, delivery and treatment accounts. They cover a company that sells more than testosterone, and not every entry identifies the program. Do not treat all of these records as TRT-only experiences.^{36 12}

Trustpilot identifies Maximus as having a paid platform subscription. That is a relationship with the review platform, not proof that an individual reviewer was paid. We have not authenticated these customers' treatment records or established whether every reviewer had a separate incentive.³⁶

Which leads to our actual verdict:

Billing and fulfillment deserve scrutiny. Medical risk still needs a separate clinical assessment.

A good review score cannot remove medication risks, and careful planning cannot prevent every billing problem.^{22 29}

Two public customer accounts

These are attributable public reviews. They describe two people's experiences. They do not prove anything about safety, effectiveness, typical results, or current policy.

Anthony truschinger, August 18, 2026 — describes Maximus support as responsive and helpful while on a testosterone program. We're using the service observation only, not any claim about results.³⁶

Steve, published August 21, 2026 — describes unexpected charges after setting up his account, saying he "did not see anything in the checkout box." He also reports receiving a full refund after escalating.³⁶

We're including Steve's complaint and his resolution, because leaving either one out would misrepresent what happened.

The incomplete-enrollment complaints

The BBB file also contains incomplete-enrollment billing complaints. The entries show reported experiences, not an audit of the customers' bank records.¹²

Three separate BBB complaints describe charges during an incomplete enrollment or an enrollment the customer disputed.

• July 15, 2026 — the customer said they began creating an account, never completed enrollment, and were charged $399.95 in February, April, and July 2026. $1,199.85 total, with no products received according to the complaint. In its next-day response, Maximus said it refunded the charges and cancelled the account.¹²
• April 6, 2026 — the customer reported requesting information about transferring care, declining the appointment offered, then being charged $20 once and $135 monthly for three months. Maximus responded: "We apologize unreservedly for the repeated charges you incurred without receiving any product or service, and particularly for the fact that billing continued after our support team had already confirmed the error on our end." The company said it processed a full refund.¹²
• March 12, 2026 — the customer said they entered card details, stopped at the ID verification step, never finished setup, and were charged anyway. Maximus said it issued a full refund and closed the account.¹²

And here's the piece to check before entering a card: Maximus's own billing policy separates billing dates from shipment timing, and allows billing before onboarding is complete. That makes the first-charge trigger a real question. It does not establish that every disputed charge was authorized or correctly applied.²

In a June 2026 response, Maximus said: "we are actively reviewing our cancellation workflows to ensure they are clearer and more accessible for all members." That is a company statement, not proof a particular workflow was changed or tested.¹²

Reduce billing surprises in three steps:

1. Don't enter a card until you intend to enroll. Not "to see the price." To enroll.
2. If you start intake and stop partway, email support that day and get written confirmation that no subscription was created.
3. Check charges when they appear and review each statement. Do not wait until a second or third charge to ask about an unfamiliar subscription. The public responses above report refunds; that does not guarantee the same result in a new dispute.

The other patterns, stated plainly

Refill delays. One member since November 2025 filed in April 2026 describing a third delayed refill, difficulty reaching support, and chat replies taking one to five days. Another complaint described a three-month plan at $280 a month and a delayed January shipment. These are historical customer accounts, not current prices or a measured delay rate. If a refill is delayed, ask the prescribing clinician for a continuity-of-care plan rather than changing the medicine yourself.¹²

Clinical responsiveness. One complaint from March 2026 describes reporting worsening lab markers and side effects, asking for physician review, and receiving an automatic medication shipment instead. Maximus said the assigned physician subsequently responded through secure messaging. That's one person's account. It's not proof of a pattern. It is worth knowing before you rely on portal messaging for an important clinical question.¹²

Why there are no success-story quotes on this page

You've probably noticed we haven't shown you a single before-and-after.

That's deliberate. A testimonial about a person's treatment result does not establish what another person should expect. We have not authenticated every testimonial, and we will not use one as evidence that a medicine is safe or effective.

We're not going to use one man's outcome to suggest anything about yours. What we'll show you instead is the complaint record, with dates, and the company's responses next to it. You can decide what it means.

---

Who handles clinical questions, refills and medical records?

Maximus's public process separates lab review, prescribing, pharmacy processing and support. A billing renewal is not a refill approval, and the pages do not establish a guaranteed response time for your assigned clinician or a medical-record transfer deadline.^{6 2}

The published timeline is not a delivery promise

Provider-stated process, not times we measured.^{6 2}

The product pages advertise messaging access at any time. That does not mean a doctor promises to reply immediately. The help center lists weekday support chat hours; administrative support and clinical advice are not the same service.^{1 21}

Ask who answers a medical question, how to request a visit, when the clinician is available, and what happens when the usual clinician is away. Blood pressure, blood counts, symptoms and side effects need a monitoring plan—not just a recurring testosterone result.²⁹

Get the clinician and pharmacy names

Maximus's Terms distinguish the platform from the affiliated medical practices providing care. Ask for the practice's legal name, the assigned clinician's name and license, and the dispensing pharmacy's legal name and location. Check the relevant state medical and pharmacy boards once those identities are known.^{5 37}

We cannot verify a patient-specific license or dispensing arrangement without those names. A general “board-certified” or “licensed pharmacy” badge does not identify the professional responsible for your care.

Ask how records move with you

Before a transfer, ask the treating practice how to obtain laboratory reports, visit notes and your medication list, whether there is a charge, and how long it takes. Request a care handoff and refill plan from the clinicians involved. The public pages reviewed do not establish a Maximus-specific records-release fee or deadline.

Use the care team's designated channel for medical details. Maximus's Terms warn that ordinary email and SMS are not encrypted; do not treat a billing support email as a private medical-record portal.⁵

---

Can you use Maximus in your state, and will insurance pay?

Maximus states it does not accept insurance — it's cash-pay. Its Terms limit treatment to states where it is authorized, and we did not find a complete public, treatment-specific state list. Federal controlled-substance telemedicine flexibilities run through December 31, 2026, but they do not remove state licensing or clinical requirements.^{2 5 38 37}

Three things to sort out here.

Insurance. Maximus's billing documentation states it does not accept insurance. Maximus displays HSA/FSA eligibility, which is different from insurance coverage. It does not guarantee that your account administrator will approve every charge or that an insurer will reimburse it. Check your own plan rules.^{2 1}

Your state. Maximus's Terms say the program is limited to states where it's authorized to provide services. We could not find a complete treatment-specific state list. Confirm your state during intake, before you pay, and ask which licensed prescriber will be handling your care.⁵

Do not borrow a state count from a different Maximus product. Its comprehensive lab plans list 47 states, excluding New York, New Jersey and Rhode Island; that is not a verified map of where its testosterone programs are available.²⁶

The telemedicine rules. Testosterone is Schedule III, and prescribing controlled substances by telemedicine has been governed by a series of federal flexibilities. The current extension runs through December 31, 2026. It allows qualifying DEA-registered practitioners to prescribe Schedule II–V medicines through audio-video telemedicine without a prior in-person evaluation when all applicable requirements are met. It is not a questionnaire-only prescribing permission.^{8 38}

That's a real date, and it's worth knowing it exists rather than assuming online prescribing is permanently settled. State rules can also add requirements the federal rule doesn't. Tell the practice where you will physically be during appointments, including travel or a move, and confirm whether an in-person examination is needed for your care.³⁷

None of that means Maximus can prescribe to anyone anywhere. It means the door is currently open, with conditions, and the conditions have changed before.

---

Who is Maximus right for, and who should choose something else?

Our editorial judgment: Maximus is worth comparing for a cash-pay adult whose clinician finds the proposed treatment appropriate and whose written quote resolves the costs, medicine and commitment. It is not the starting point when you still need a diagnosis, fertility-focused care or an examination the service cannot arrange. The cheapest plan is also not the most flexible.^{1 4 20}

Find yourself in this table. It's the fastest two minutes on this page.

Care-route judgments are based on the published offers, subscription terms and clinical guidance. They are not a diagnosis or a finding that a specific person qualifies for treatment.^{1 4 20 29}

Readers who need a different setting can compare online care with a local clinician. Readers who need a different medicine can compare testosterone treatment formats.

Chest pain, sudden or severe trouble breathing, or sudden vision changes need emergency assessment—call 911 or seek emergency care. New one-sided leg swelling or pain also needs urgent medical assessment. Do not wait for a support message.³⁹

Find yourself in the table above, then use the tool to organize your care-route questions around testing, your state and your fertility plans. It does not interpret your lab results or determine eligibility.

→ Get your care route with Find My TRT Path

---

Which 7 questions should Maximus answer in writing before you pay?

Get the exact medicine, full price, commitment and care contacts in writing before entering a payment agreement. The questions below turn the gaps in the public pages into a checklist you can copy, print and save.

We couldn't confirm everything from public pages. So rather than guess, we turned each gap into a question. Copy these. Ask them at intake or in support chat. Save the answers.

1. Which plan length unlocks the price I'm seeing, and what is my exact monthly charge at my prescribed amount? The advertised rate is not a quote. Ask for the amount due today, all scheduled charges, the total committed amount, and whether medicine, consultations, video visits, shipping and supplies are included.

2. What's my renewal amount, my renewal date, and does this plan auto-renew? Write down the next charge date and the term-renewal date. Confirm the renewed commitment length and any separate annual lab-plan renewal.

3. If I cancel in month two, what do I still owe? Get the number, not the policy language. Also ask how Terms section 4.1 applies if a healthcare provider determines you cannot continue for health reasons, and what happens financially if treatment is not prescribed or is delayed.

4. Exactly which medicines are in my program, at what amounts — and does it include enclomiphene or hCG? This matters most if fertility is on your mind. Ask whether the finished medicine is FDA-approved or compounded. The enclomiphene-only page currently includes text describing enclomiphene plus tadalafil; that inconsistency does not establish what your prescription contains. The marketing page is not your label.⁴⁰

5. What will labs cost me across the first twelve months, and is any lab panel a separate auto-renewing subscription? Ask for the exact baseline panel, a second diagnostic morning test when needed, and each follow-up panel with its date and price. Confirm whether the twelve-month test falls inside or just after your budget period. List every separate subscription and renewal date.

6. Is my state covered, and which licensed prescriber and medical practice will be handling my care? A credential badge on a homepage is not the clinician assigned to you. Ask how to arrange visits, the clinical response-time expectation, what needs in-person care, and how to obtain your records—including any fee or release timeline.

7. Which pharmacy dispenses my medication? Get the name. If you ever transfer care, you'll need it. Also ask what happens if a refill is delayed, which supplies are included, and how the clinical team handles a change of pharmacy or a shortage.

If a company won't answer these in writing, that answer is also information.

Use Maximus's published billing guidance and subscription policy when asking for clarification. Once the treatment category is settled with your clinician, compare the corresponding cream, injection, oral testosterone or enclomiphene offer against the written answer—not the headline price alone.

---

How did we check this page?

We compared Maximus's four product pages, its program comparison table, Terms of Use, subscription and refund policy, billing and lab-testing help articles, published lab pricing, public BBB records and its Trustpilot profile on September 11, 2026. We then checked the prevalence claims against the original research available and medical or regulatory claims against official sources.

Our method is called How We Review TRT Providers. It separates four things that most review pages blend together:

• Verified fact — an authoritative source establishes the fact; we identify the source and date. Reading a provider's claim does not independently verify its performance.
• Provider-stated fact — the company says it. We attribute it and don't restate it as proven.
• Customer-experience signal — an attributable public account. It can describe experience. It cannot establish safety, effectiveness, typical results, or current policy.
• Editorial conclusion — our judgment, built from the verified facts above and labeled as ours.

We show the cost calculation and its missing inputs rather than repeating a starting price. The published data do not support a complete patient-specific bill. This page does not assign Maximus a numeric provider score.

TRT Provider Guide is not a clinic, pharmacy, laboratory, drug manufacturer, insurer, or medical practice. We don't prescribe, diagnose, or interpret your labs. Nothing here determines whether you're eligible for treatment.

What we'd change if we're wrong: prices, policies, ratings, and regulations all move. If something here is out of date, send the supporting record through our corrections process and we'll check it. See our editorial standards and privacy policy.

---

Maximus TRT reviews: what is our final verdict?

Maximus is worth comparing for a defined cash-pay reader, and it's not the simple $99.99 decision the ads suggest. Our verdict depends on a proper clinical evaluation and a written offer that resolves the medicine, full cost, access and cancellation terms.

The $99.99 needs a six-month commitment for injections or cream, or twelve months for enclomiphene. Those month-to-month rates are $199.99. Labs are extra; four tests modeled at the two published kit prices total $396 to $399.96, but the complete required bill is not established. The reviewed offers advertise compounding, and Maximus says it does not accept insurance. The ordinary commitment rule keeps the term payable, with a health-related exception in the Terms that needs written clarification.^{1 25 21 2 5 4}

The Trustpilot profile displayed 4.4 from 1,067 reviews. Billing, delivery and clinical communication all appear in the complaint record. The Maximus Tribe BBB profile displayed B−; a second profile displayed B+. None is a medical quality score.^{36 12 10 11}

If you take one thing from this page: confirm the diagnosis and the full commitment before paying. Compare month-to-month pricing when flexibility matters, ask your clinician about appropriate repeat morning testing, and raise fertility plans before treatment. Do not let a subscription discount make the medical decision for you.

---

What else should you know about Maximus TRT?

The remaining questions concern the exact medicine, testing, access and what happens after enrollment. These answers summarize the public record checked on September 11, 2026; personal prescribing and contract questions still need an answer from the responsible practice or provider.

Is Maximus TRT legit?

Maximus has active public treatment offers and a documented testing and clinical-review process. That is not proof of an individual clinician's license, a pharmacy's quality or a medicine's suitability. Its Terms place clinical care with affiliated practices; the FDA warning described above concerned separate compounded weight-loss marketing, not a TRT recall.^{1 6 5 7}

How much does Maximus TRT cost per month?

Advertised ongoing rates run $99.99 to $249.99 per month for the testosterone programs compared here. The cream and injections reach $99.99 on a six-month plan; oral testosterone reaches $149.99 on a six-month plan. Enclomiphene, which is not TRT, reaches $99.99 on a twelve-month plan. Month-to-month rates are higher, and labs are billed separately.^{1 21}

Is Maximus testosterone FDA-approved?

The reviewed pages advertise compounding-pharmacy fulfillment, and the oral page explicitly describes a custom-compounded formulation. We did not identify a named FDA-approved finished testosterone product in those offers. A compounded medicine is not FDA-approved; ask for the exact prescription and dispensing pharmacy.^{1 19 22}

Can you cancel a Maximus plan?

You can turn off auto-renewal through the dashboard or support email. The ordinary rule keeps a committed term payable, but Terms section 4.1 contains a provider-determined health-related exception. The newer refund policy does not reconcile that exception, so get its application to your plan in writing. Pausing is not the same as ending renewal or the payment obligation.^{4 5 35}

Does Maximus require blood work?

Yes. Maximus describes baseline testing and accepts qualifying outside bloodwork from the past six months. Its help article lists total testosterone, free testosterone or SHBG, LH and FSH for enclomiphene, with PSA and hematocrit additionally required for testosterone protocols. Confirm the full panel and whether a second diagnostic early-morning test is required and separately charged.^{21 6}

Is Maximus enclomiphene the same as TRT?

No. Enclomiphene contains no testosterone. It can stimulate the body's hormone signaling rather than replace testosterone directly. It is a different treatment category, and evidence from selected men with secondary hypogonadism does not establish that it fits every cause of low testosterone.¹⁴

Does Maximus TRT affect fertility?

It can. Maximus's injectable and cream pages carry explicit warnings about reduced sperm production. A combination footnote or a maintained hormone marker does not guarantee sperm preservation, pregnancy or later recovery. Discuss fertility plans with a qualified clinician before treatment.^{16 17 15 3}

Does insurance cover Maximus?

Maximus states that it does not accept insurance. That differs from a plan-specific decision about reimbursement for a particular service. HSA/FSA marketing also does not guarantee payment eligibility for every expense; check your administrator's rules.^{2 1}

What is Maximus's BBB rating?

The Maximus Tribe profile displayed B−, not accredited, with 18 complaints. The separate Maximus Health Inc. profile displayed B+, not accredited, with seven complaints. Both were checked September 11, 2026. They are not medical ratings, and the counts have not been combined.^{10 11}

Is Maximus available in my state?

Its Terms limit the program to states where it is authorized. We did not find a complete public list for each testosterone treatment, so confirm your state, exact treatment and prescriber before paying. A state count for Maximus's comprehensive lab service does not establish TRT availability.^{5 26}

How long until Maximus TRT works?

There is no verified Maximus-specific timeline that predicts your result. The evidence discussed here does not support a promise of improved energy, mood or focus within a set number of weeks. Ask the clinician which symptoms treatment is intended to address, when they will review your progress, and what happens if it does not help.²⁹

What happens to my price after the first year?

The Terms say committed plans renew for the same duration at the then-current rate, unless renewal is cancelled. They also provide for advance renewal and price-change notice. Do not assume your first-term discount, price or testing charges will stay unchanged.^{5 4}

---

This page is educational information, not medical advice. It does not diagnose low testosterone, interpret lab results, determine medical eligibility, or guarantee that any provider will prescribe treatment. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription from an appropriately licensed prescriber.⁸

Prices, policies, ratings and regulations were checked on September 11, 2026 and can change. TRT Provider Guide may earn a commission from some providers linked on this site. The provider links in this article are direct public-source links, not affiliate enrollment links. See our affiliate disclosure.

Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.

Sources checked September 11, 2026

1. Maximus, current product pages checked September 11, 2026: injectable testosterone, testosterone cream, oral testosterone, and enclomiphene-only. Prices and service descriptions are provider-stated, not patient-specific quotes.

2. Maximus Help Center, Billing & Subscriptions, dated July 14, 2026; checked September 11, 2026.

3. American Society for Reproductive Medicine and American Urological Association, Diagnosis and treatment of infertility in men: guideline part II. Testosterone, fertility, selected non-testosterone therapies and off-label SERM use; checked September 11, 2026.

4. Maximus Help Center, Return, Refund, & Subscription Policy, dated July 15, 2026; checked September 11, 2026.

5. Maximus, Terms of Use, especially the subscription terms and section 4.1. Includes ordinary commitment obligations, the provider-determined health-related exception, renewal provisions and clinical-practice disclosures; checked September 11, 2026.

6. Maximus Help Center, Lab Testing Overview, dated May 11, 2026; checked September 11, 2026.

7. U.S. Food and Drug Administration, Warning letter: Maximus Health, Inc., doing business as Maximus, June 8, 2026. The cited products are compounded semaglutide and tirzepatide, not testosterone; checked September 11, 2026.

8. U.S. Drug Enforcement Administration, Drug Scheduling. Testosterone is listed in Schedule III; checked September 11, 2026.

9. Innerbody, Maximus review, dated January 29, 2026. Used only to identify the published historical F-rating claim, not as medical or licensing evidence.

10. Better Business Bureau, Maximus Tribe business profile. B−, not accredited, 18 complaints at the September 11, 2026 check.

11. Better Business Bureau, Maximus Health Inc. business profile. B+, not accredited, seven complaints at the September 11, 2026 check. Not combined with the Maximus Tribe profile.

12. Better Business Bureau, Maximus Tribe customer complaints. Public allegations, company responses, category definitions and dates; checked September 11, 2026. The calendar-day differences are our calculations.

13. Better Business Bureau, Maximus Tribe customer complaints, page 2. Older entries, including the October 10, 2025 complaint with a May 28, 2026 response; checked September 11, 2026.

14. Kim ED et al., Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement, BJU International, 2016. A study of selected men with secondary hypogonadism—not every Maximus formulation or a pregnancy guarantee.

15. Maximus, Testosterone treatments. Comparison table, fertility footnotes, combination-price range and consultation-inclusion statements; checked September 11, 2026.

16. Maximus, Injectable Testosterone. Product, carrier-oil, price, service and risk disclosures; checked September 11, 2026.

17. Maximus, Testosterone Cream. Price, product and fertility/transfer disclosures; checked September 11, 2026.

18. ASCEND Therapeutics, AndroGel 1.62% prescribing information, boxed warning and section 5.2 on secondary exposure to testosterone. Used for the contact-exposure risk, not to transfer this gel's application instructions to a Maximus preparation; checked September 11, 2026.

19. Maximus, Oral Testosterone. Custom-compounded formulation and current offers; checked September 11, 2026.

20. Endocrine Society, Testosterone Therapy for Hypogonadism Guideline Resources. Diagnostic confirmation, evaluation of the cause, fertility and monitoring; checked September 11, 2026.

21. Maximus Help Center, Lab Testing: Costs and Policies, dated July 23, 2026; checked September 11, 2026.

22. U.S. Food and Drug Administration, Understanding the Risks of Compounded Drugs. Compounded medicines are not FDA-approved; checked September 11, 2026.

23. U.S. Food and Drug Administration, FDA presentations to the Pharmacy Compounding Advisory Committee, June 8, 2022, enclomiphene section, including PDF pages 36–39. FDA clinical and application-history material, not the separate industry presentation; checked September 11, 2026.

24. Organon, Pregnyl prescribing information, Indications and Usage. Includes selected cases of male hypogonadotropic hypogonadism, not a guarantee of fertility preservation with added testosterone.

25. Maximus, At-Home Testosterone Test. Product-page price of $99.99 each and advertised ten-marker panel; checked September 11, 2026.

26. Maximus, Comprehensive Lab Testing. Separate annual plans, one-time add-on panels and laboratory-product state exclusions; checked September 11, 2026.

27. U.S. Food and Drug Administration, FDA issues class-wide labeling changes for testosterone products, February 28, 2025. Blood-pressure warnings and approved testosterone formulations; checked September 11, 2026.

28. U.S. Food and Drug Administration, Testosterone Information. Includes the June 2026 requested labeling updates; checked September 11, 2026.

29. Endocrine Society, Statement on Testosterone Replacement Therapy, July 16, 2026. Current diagnosis, testing and risk-assessment statement; checked September 11, 2026.

30. Maximus, Oral testosterone and enclomiphene white paper. Provider-published research; not independent verification of individual fertility or typical results.

31. Maximus, Testosterone cream with enclomiphene white paper. Provider-published hormone-marker findings; not proof of preserved sperm or pregnancy.

32. American Society for Reproductive Medicine and American Urological Association, Diagnosis and treatment of infertility in men: guideline part I. Clinical evaluation and limits of semen parameters; checked September 11, 2026.

33. Araujo AB et al., Prevalence of symptomatic androgen deficiency in men, Journal of Clinical Endocrinology & Metabolism, 2007. The published abstract reports about 24% with low total testosterone and 5.6% meeting the symptomatic definition.

34. Mulligan T et al., Prevalence of hypogonadism in males aged at least 45 years: the HIM study, International Journal of Clinical Practice, 2006. Its study definition includes men already diagnosed and receiving androgen treatment, irrespective of their measured value.

35. Maximus Help Center, Why was I charged after pausing my subscription?, dated April 29, 2026; checked September 11, 2026.

36. Trustpilot, Maximus company profile and customer reviews. Displayed 4.4/5 from 1,067 reviews at the September 11, 2026 check. Includes the Anthony truschinger and Steve accounts, platform-reported response metrics and the paid-platform-subscription disclosure. These are public accounts, not independently authenticated treatment records.

37. U.S. Department of Health and Human Services, Licensing across state lines. Patient location and professional authorization remain relevant; checked September 11, 2026.

38. U.S. Drug Enforcement Administration, DEA extends telemedicine flexibilities to ensure continued access to care, December 31, 2025. Extension through December 31, 2026; checked September 11, 2026.

39. MedlinePlus, Testosterone Injection. Serious symptoms and safety warnings; checked September 11, 2026. Product-specific instructions are not transferred to Maximus formulations.

40. Maximus, Enclomiphene-only. The page includes combination wording mentioning tadalafil; checked September 11, 2026. That text does not identify any individual prescription.